UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 266

Sortiert nach

Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort

Gastroenterology (New York, N.Y. 1943), 2007-08, Vol.133 (2), p.412-422

2007

Volltextzugriff (PDF)

Prior Appendectomy and the Onset and Course of Crohn’s Disease in Chinese Patients

Gastroenterology research and practice, 2019, Vol.2019, p.8463926-7

2019

Volltextzugriff (PDF)

The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway

Quality of life research, 2023-03, Vol.32 (3), p.691-699

2023

Volltextzugriff (PDF)

Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring

Scandinavian journal of gastroenterology, 2023-08, Vol.58 (8), p.863-873

2023

Volltextzugriff (PDF)

Low-Dose Computed Tomography for the Optimization of Radiation Dose Exposure in Patients with Crohn’s Disease

Gastroenterology research and practice, 2018-01, Vol.2018, p.1768716-10

2018

Volltextzugriff (PDF)

Chronic inflammatory bowel disease and COVID-19

Tidsskrift for den Norske Lægeforening, 2020-05, Vol.140 (7)

Moum, Bjørn

2020

Volltextzugriff (PDF)

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

Gut, 2013-03, Vol.62 (3), p.368-375

2013

Volltextzugriff (PDF)

Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic

Scandinavian journal of gastroenterology, 2021-05, Vol.56 (5), p.545-551

2021

Volltextzugriff (PDF)

Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists

Gastroenterology research and practice, 2018-01, Vol.2018, p.8715263-9

2018

Volltextzugriff (PDF)

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

Gastroenterology (New York, N.Y. 1943), 2018-10, Vol.155 (4), p.1079-1089.e3

2018

Volltextzugriff (PDF)

Fluoride: a risk factor for inflammatory bowel disease?

Scandinavian journal of gastroenterology, 2016-09, Vol.51 (9), p.1019-1024

2016

Volltextzugriff (PDF)

Novel Approaches to Ileocolic and Perianal Fistulising Crohn’s Disease

Gastroenterology research and practice, 2018-01, Vol.2018, p.3159543-14

2018

Volltextzugriff (PDF)

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

Gut, 2017-04, Vol.66 (4), p.611

2017

Volltextzugriff (PDF)

Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls

Inflammatory bowel diseases, 2011-07, Vol.17 (7), p.1564-1572

2011

Volltextzugriff (PDF)

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

Scandinavian journal of gastroenterology, 2009-01, Vol.44 (4), p.431-440

2009

Volltextzugriff (PDF)

Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series

Inflammatory bowel diseases, 2018-04, Vol.24 (5), p.997-1004

2018

Volltextzugriff (PDF)

Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study)

Scandinavian journal of gastroenterology, 2023-11, Vol.ahead-of-print (ahead-of-print), p.1-7

2023

Volltextzugriff (PDF)

Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study

Journal of Crohn's and colitis, 2017-03, Vol.11 (3), p.297

2017

Volltextzugriff (PDF)

Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study

Clinical gastroenterology and hepatology, 2007-12, Vol.5 (12), p.1430-1438

2007

Volltextzugriff (PDF)

Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside

Alimentary pharmacology & therapeutics, 2019-08, Vol.50 (4), p.397-406

2019

Volltextzugriff (PDF)

Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population

Scandinavian journal of gastroenterology, 2017-01, Vol.52 (1), p.100-106

2017

Volltextzugriff (PDF)

Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)

Journal of Crohn's and colitis, 2023-04, Vol.17 (4), p.497-503

2023

Volltextzugriff (PDF)

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2016-10, Vol.151 (4), p.660-669.e4

2016

Volltextzugriff (PDF)

The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients

Scandinavian journal of gastroenterology, 2022-01, Vol.57 (6), p.683-689

2022

Volltextzugriff (PDF)

Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population

Scandinavian journal of gastroenterology, 2018-06, Vol.53 (6), p.692-699

2018

Volltextzugriff (PDF)

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(217)

Publikationsform

Sprache

Englisch
(225)
Norwegisch
(59)
Japanisch
(26)
Bokmål, Norwegian; Norwegian Bokmål
(21)
Schwedisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort

Prior Appendectomy and the Onset and Course of Crohn’s Disease in Chinese Patients

The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway

Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring

Low-Dose Computed Tomography for the Optimization of Radiation Dose Exposure in Patients with Crohn’s Disease

Chronic inflammatory bowel disease and COVID-19

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic

Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

Fluoride: a risk factor for inflammatory bowel disease?

Novel Approaches to Ileocolic and Perianal Fistulising Crohn’s Disease

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series

Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study)

Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study

Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study

Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside

Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population

Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients

Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population

Suchergebnisse filtern